These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7303769)

  • 1. [Thrombosis therapy and the prophylaxis of thrombosis recurrences in obstetrics].
    Voigt T; Voigt H; Wegner H; Scheel H
    Z Gesamte Inn Med; 1981 Jun; 36(12):418-21. PubMed ID: 7303769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects in the therapy of thrombosis and prevention of recurrence in pregnancy].
    Voigt T; Voigt H; Scheel H; Wegner H
    Zentralbl Gynakol; 1987; 109(3):169-72. PubMed ID: 3564756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antithrombosis prophylaxis with subcutaneous calciparin in high-risk pregnancies].
    Grio R; Patriarca A; Rosa MO; Alovisi C; Rustichelli S; Piacentino R
    Minerva Ginecol; 1984; 36(1-2):59-60. PubMed ID: 6538944
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic prophylaxis and treatment in thrombophilic disorders in gynaecology and obstetrics].
    Dulícek P; Penka M; Binder T; Unzeitig V
    Vnitr Lek; 2006 Mar; 52 Suppl 1():58-62. PubMed ID: 16637451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of thrombosis in pregnancy (author's transl)].
    Joswig EH; Joswig-Priewe H; Koestering H; Walther C
    Geburtshilfe Frauenheilkd; 1975 Dec; 35(12):932-7. PubMed ID: 1213258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy--a longitudinal safety study.
    Blombäck M; Bremme K; Hellgren M; Siegbahn A; Lindberg H
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):1-9. PubMed ID: 9607113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin in pregnancy: current issues.
    Greer I; Hunt BJ
    Br J Haematol; 2005 Mar; 128(5):593-601. PubMed ID: 15725079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin therapy for congenital antithrombin III deficiency in pregnancy.
    Neerhof MG; Krewson DP; Haut M; Librizzi RJ
    Am J Perinatol; 1993 Jul; 10(4):311-2. PubMed ID: 8397570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C deficiency and pregnancy: a case report.
    Vogel JJ; de Moerloose PA; Bounameaux H
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):455-6. PubMed ID: 2915872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications and monitoring of antithrombotic prophylaxis for venous thromboembolism during pregnancy and post-partum].
    Jude B; Wibaut B; Depret S
    Ann Med Interne (Paris); 2003; 154(5-6):361-5. PubMed ID: 15027591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of thromboprophylaxis in pregnancy caused by dual deficiencies of protein S and protein C.
    Morikawa M; Yamada H; Kato EH; Wada S; Suzuki S; Sakuragi N; Minakami H
    Semin Thromb Hemost; 2005 Jun; 31(3):261-5. PubMed ID: 16052394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic risk during pregnancy and puerperium in women with APC-resistance--effective subcutaneous heparin prophylaxis in a pregnant patient.
    De Stefano V; Mastrangelo S; Paciaroni K; Ireland H; Lane DA; Scirpa P; Bizzi B; Leone G
    Thromb Haemost; 1995 Aug; 74(2):793-4. PubMed ID: 8585024
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy.
    Zotz RB; Gerhardt A; Scharf RE
    Semin Thromb Hemost; 2003 Apr; 29(2):143-54. PubMed ID: 12709917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed mini-dose warfarin for prophylaxis of thromboembolic disease in pregnancy: a safe alternative for the fetus?
    Porreco RP; McDuffie RS; Peck SD
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):806-7. PubMed ID: 8469479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing the risk of recurrent thromboembolism and pre-existing osteoporosis in pregnancy.
    Kyei-Mensah A; Machin SJ; Jacobs HS
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):77-81. PubMed ID: 7742521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin.
    Gerdsen F; Luxembourg B; Langer F; Bauersachs R; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):477-81. PubMed ID: 18685429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilia, thrombosis and pregnancy.
    Eldor A
    Thromb Haemost; 2001 Jul; 86(1):104-11. PubMed ID: 11486995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.